Page 140 - Tata_Chemicals_yearly-reports-2021-22
P. 140
Integrated Annual Report 2021-22
Certificate from Practising Company Secretary
M/s. Parikh & Associates, Practising Company Secretaries, has issued a certificate confirming that none of the Directors on the Board
of the Company has been debarred or disqualified from being appointed or continuing as Directors of companies by SEBI/MCA or
any such statutory authority. The said Certificate is annexed to this Report on Corporate Governance.
Distribution of Shareholding as on March 31, 2022
Number Amount % to Number of % to total
Range
of Shares (`) Capital Shareholders Shareholders
1 to 500 3,06,40,825 30,64,08,250 12.03 6,16,859 96.62
501 to 1,000 89,80,336 8,98,03,360 3.52 11,865 1.86
1,001 to 2,000 79,89,886 7,98,98,860 3.14 5,531 0.87
2,001 to 3,000 41,36,271 4,13,62,710 1.62 1,656 0.26
3,001 to 4,000 26,03,355 2,60,33,550 1.02 732 0.11
4,001 to 5,000 21,80,616 2,18,06,160 0.86 471 0.07
5,001 to10,000 53,93,279 5,39,32,790 2.12 755 0.12
Above 10,000 19,28,31,710 1,92,83,17,100 75.69 553 0.09
Total 25,47,56,278 2,54,75,62,780 100.00 6,38,422 100.00
Category of Shareholding as on March 31, 2022
Category Number of Shares Percentage (%)
Promoter and Promoter Group 9,67,48,953 37.98
Resident Individuals 6,31,33,640 24.78
Foreign Holdings 3,75,39,130 14.74
Public Financial Institutions 3,01,99,013 11.85
Government/Government Companies 71,948 0.03
Other Companies, Mutual Funds 2,39,52,393 9.40
Nationalised Banks 61,337 0.02
Alternative Investment Fund 16,86,077 0.66
Bodies Corporate - Non Banking Financial Companies 3,844 0.00
IEPF 13,59,943 0.54
Total 25,47,56,278 100.00
Dematerialisation of shares and liquidity
The Company’s shares are compulsorily traded in dematerialised form.
(%)
As on As on As on
Shares held in
March 31, 2022 March 31, 2021 March 31, 2020
Physical form 1.65 1.76 1.82
Electronic form with NSDL 89.85 90.83 92.72
Electronic form with CDSL 8.50 7.41 5.46
The Company’s Ordinary Shares are regularly traded on BSE and NSE.
Outstanding Global Depository Receipts (GDRs) or American Depository Receipts (ADRs) or warrants or any
convertible instruments, conversion date and likely impact on equity
The Company has not issued any GDRs or ADRs or warrants or any convertible instruments during the year under review.
138